Differential transcriptional profiles induced by amphotericin B formulations on human monocytes during response to hyphae of Aspergillus fumigatus

References

• Nucci M, Anaissie E. Fungal infections in hematopoietic stem cell transplantation and solid-organ transplantation – focus on aspergillosis. Clin Chest Med 2009; 30: 295–306, vii.
   PubMed Web of Science ®Google Scholar
• Ben-Ami R, Lewis RE, Kontoyiannis DP. Invasive mould infections in the setting of hematopoietic cell transplantation: current trends and new challenges. Curr Opin Infect Dis 2009; 22: 376–384.
   PubMed Web of Science ®Google Scholar
• Trullas JC, Cervera C, Benito N, . Invasive pulmonary aspergillosis in solid organ and bone marrow transplant recipients. Transplant Proc 2005; 37: 4091–4093.
   PubMed Web of Science ®Google Scholar
• Groll AH, Walsh TJ. Antifungal chemotherapy: advances and perspectives. Swiss Med Wkly 2002; 132: 303–311.
   PubMed Web of Science ®Google Scholar
• Sole A. Invasive fungal infections in lung transplantation: role of aerosolised amphotericin B. Int J Antimicrob Agents 2008; 32(Suppl. 2): S161–165.
   PubMedGoogle Scholar
• Walsh TJ, Anaissie EJ, Denning DW, . Infectious Diseases Society of America. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 327–360.
   PubMed Web of Science ®Google Scholar
• Olson JA, Adler-Moore JP, Schwartz J, Jensen GM, Proffitt RT. Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model. Antimicrob Agents Chemother 2006; 50: 2122–2131.
   PubMed Web of Science ®Google Scholar
• Mouton JW, Te Dorsthorst DT, Meis JF, Verweij PE. Dose-response relationships of three amphotericin B formulations in a non-neutropenic murine model of invasive aspergillosis. Med Mycol 2009; 47: 1–7.
   PubMedGoogle Scholar
• Wingard JR, White MH, Anaissie E, . A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group. Clin Infect Dis 2000; 31: 1155–1163.
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Finberg RW, Arndt C, . Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. N Engl J Med 1999; 340: 764–771.
   PubMed Web of Science ®Google Scholar
• Dockrell DH. Salvage therapy for invasive aspergillosis. J Antimicrob Chemother 2008; 61(Suppl. 1): i41–44.
   Google Scholar
• Willger SD, Grahl N, Cramer RA, Jr. Aspergillus fumigatus metabolism: clues to mechanisms of in vivo fungal growth and virulence. Med Mycol 2009; 47(Suppl. 1): S72–79.
   Google Scholar
• Auberger J, Lass-Florl C, Ulmer H, . Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies. Int J Hematol 2008; 88: 508–515.
   PubMed Web of Science ®Google Scholar
• Dotis J, Simitsopoulou M, Dalakiouridou M, . Effects of lipid formulations of amphotericin B on activity of human monocytes against Aspergillus fumigatus. Antimicrob Agents Chemother 2006; 50: 868–873.
   PubMed Web of Science ®Google Scholar
• Martin E, Stuben A, Gorz A, Weller U, Bhakdi S. Novel aspect of amphotericin B action: accumulation in human monocytes potentiates killing of phagocytosed Candida albicans. Antimicrob Agents Chemother 1994; 38: 13–22.
   PubMed Web of Science ®Google Scholar
• Roilides E, Walsh TJ, Rubin M, Venzon D, Pizzo PA. Effects of antifungal agents on the function of human neutrophils in vitro. Antimicrob Agents Chemother 1990; 34: 196–201.
   PubMed Web of Science ®Google Scholar
• Segal BH. Role of macrophages in host defense against aspergillosis and strategies for immune augmentation. Oncologist 2007; 12 (Suppl. 2): 7–13.
   PubMedGoogle Scholar
• Rogers PD, Pearson MM, Cleary JD, Sullivan DC, Chapman SW. Differential expression of genes encoding immunomodulatory proteins in response to amphotericin B in human mononuclear cells identified by cDNA microarray analysis. J Antimicrob Chemother 2002; 50: 811–817.
   PubMed Web of Science ®Google Scholar
• Turtinen LW, Prall DN, Bremer LA, Nauss RE, Hartsel SC. Antibody array-generated profiles of cytokine release from THP-1 leukemic monocytes exposed to different amphotericin B formulations. Antimicrob Agents Chemother 2004; 48: 396–403.
   PubMed Web of Science ®Google Scholar
• Turtinen LW, Croswell A, Obr A. Microarray analysis of amphotericin B-treated THP-1 monocytic cells identifies unique gene expression profiles among lipid and non-lipid drug formulations. J Chemother 2008; 20: 327–335.
   PubMed Web of Science ®Google Scholar
• Simitsopoulou M, Roilides E, Dotis J, . Differential expression of cytokines and chemokines in human monocytes induced by lipid formulations of amphotericin B. Antimicrob Agents Chemother 2005; 49: 1397–1403.
   PubMed Web of Science ®Google Scholar
• Cortez KJ, Lyman CA, Kottilil S, . Functional genomics of innate host defense molecules in normal human monocytes in response to Aspergillus fumigatus. Infect Immun 2006; 74: 2353–2365.
   PubMedGoogle Scholar
• Rodland EK, Mattingsdal M, Olstad OK, . Expression of genes in normal human monocytes in response to Aspergillus fumigatus. Med Mycol 2008; 46: 327–336.
   PubMed Web of Science ®Google Scholar
• Loeffler J, Haddad Z, Bonin M, . Interaction analyses of human monocytes co-cultured with different forms of Aspergillus fumigatus. J Med Microbiol 2009; 58: 49–58.
   PubMedGoogle Scholar
• Barker KS, Liu T, Rogers PD. Coculture of THP-1 human mononuclear cells with Candida albicans results in pronounced changes in host gene expression. J Infect Dis 2005; 192: 901–912.
   PubMedGoogle Scholar
• Simitsopoulou M, Roilides E, Paliogianni F, . Immunomodulatory effects of voriconazole on monocytes challenged with Aspergillus fumigatus: differential role of Toll-like receptors. Antimicrob Agents Chemother 2008; 52: 3301–3306.
   PubMed Web of Science ®Google Scholar
• Li M, Liu ZH, Chen Q, . Insoluble beta-glucan from the cell wall of Candida albicans induces immune responses of human THP-1 monocytes through Dectin-1. Chinese Med J 2009; 122: 496–501.
   PubMedGoogle Scholar
• Lagoumintzis G, Christofidou M, Dimitracopoulos G, Paliogianni F. Pseudomonas aeruginosa slime glycolipoprotein is a potent stimulant of tumor necrosis factor alpha gene expression and activation of transcription activators nuclear factor kappa B and activator protein 1 in human monocytes. Infect Immun 2003; 71: 4614–4622.
   PubMed Web of Science ®Google Scholar
• Roilides E, Dimitriadou A, Kadiltsoglou I, . IL-10 exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J Immunol 1997; 158: 322–329.
   PubMed Web of Science ®Google Scholar
• Wurthwein G, Groll AH, Hempel G, . Population pharmacokinetics of amphotericin B lipid complex in neonates. Antimicrob Agents Chemother 2005; 49: 5092–5098.
   PubMed Web of Science ®Google Scholar
• Groll AH, Lyman CA, Petraitis V, . Compartmentalized intrapulmonary pharmacokinetics of amphotericin B and its lipid formulations. Antimicrob Agents Chemother 2006; 50: 3418–3423.
   PubMed Web of Science ®Google Scholar
• Baginski M, Czub J. Amphotericin B and its new derivatives – mode of action. Curr Drug Metab 2009; 10(5): 459–69.
   PubMedGoogle Scholar
• Gabrielska J, Gagos M, Gubernator J, Gruszecki WI. Binding of antibiotic amphotericin B to lipid membranes: a 1H NMR study. FEBS Lett 2006; 580: 2677–2685.
   PubMed Web of Science ®Google Scholar
• Netea MG, Ferwerda G, van der Graaf CA, Van der Meer JW, Kullberg BJ. Recognition of fungal pathogens by toll-like receptors. Curr Pharm Des 2006; 12: 4195–4201.
   PubMed Web of Science ®Google Scholar
• Netea MG, Warris A, Van der Meer JW, . Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction. J Infect Dis 2003; 188: 320–326.
   PubMed Web of Science ®Google Scholar
• Sau K, Mambula SS, Latz E, . The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism. J Biol Chem 2003; 278: 37561–37568.
   PubMed Web of Science ®Google Scholar
• Eder C. Mechanisms of interleukin-1beta release. Immunobiology 2009; 214(7): 543–53.
   PubMedGoogle Scholar
• Roilides E, Dimitriadou-Georgiadou A, Sein T, Kadiltzoglou I, Walsh TJ. Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus. Infect Immun 1998; 66: 5999–6003.
   PubMed Web of Science ®Google Scholar
• De Rosa FG, Shaz D, Campagna AC, . Invasive pulmonary aspergillosis soon after therapy with infliximab, a tumor necrosis factor-alpha-neutralizing antibody: a possible healthcare-associated case? Infect Control Hosp Epidemiol 2003; 24: 477–482.
   PubMedGoogle Scholar
• Vonk AG, Netea MG, Denecker NE, . Modulation of the pro- and anti-inflammatory cytokine balance by amphotericin B. J Antimicrob Chemother 1998; 42: 469–474.
   PubMedGoogle Scholar
• Rogers PD, Kramer RE, Chapman SW, Cleary JD. Amphotericin B-induced interleukin-1beta expression in human monocytic cells is calcium and calmodulin dependent. J Infect Dis 1999; 180: 1259–1266.
   PubMed Web of Science ®Google Scholar
• Clemons KV, Grunig G, Sobel RA, . Role of IL-10 in invasive aspergillosis: increased resistance of IL-10 gene knockout mice to lethal systemic aspergillosis. Clin Exp Immunol 2000; 122: 186–191.
   PubMed Web of Science ®Google Scholar
• Frendl G. Interleukin 3: from colony-stimulating factor to pluripotent immunoregulatory cytokine. Int J Immunopharmacol 1992; 14: 421–430.
   PubMed Web of Science ®Google Scholar
• Benczik M, Gaffen SL. The interleukin (IL)-2 family cytokines: survival and proliferation signaling pathways in T lymphocytes. Immunol Invest 2004; 33: 109–142.
   PubMed Web of Science ®Google Scholar
• Mehrad B, Moore TA, Standiford TJ. Macrophage inflammatory protein-1 alpha is a critical mediator of host defense against invasive pulmonary aspergillosis in neutropenic hosts. J Immunol 2000; 165: 962–968.
   PubMedGoogle Scholar
• Maurer M, von Stebut E. Macrophage inflammatory protein-1. Int J Biochem Cell Biol 2004; 36: 1882–1886.
   PubMed Web of Science ®Google Scholar
• Moser B, Willimann K. Chemokines: role in inflammation and immune surveillance. Ann Rheum Dis 2004; 63(Suppl. 2): ii84–ii89.
   PubMedGoogle Scholar
• Gao JL, Wynn TA, Chang Y, . Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med 1997; 185: 1959–1968.
   PubMed Web of Science ®Google Scholar
• Yu YR, Fong AM, Combadiere C, . Defective antitumor responses in CX3CR1-deficient mice. Int J Cancer 2007; 121: 316–322.
   PubMedGoogle Scholar
• Sturtevant JE, Latge JP. Interactions between conidia of Aspergillus fumigatus and human complement component C3. Infect Immun 1992; 60: 1913–1918.
   PubMed Web of Science ®Google Scholar
• Kozel TR, Wilson MA, Farrell TP, Levitz SM. Activation of C3 and binding to Aspergillus fumigatus conidia and hyphae. Infect Immun 1989; 57: 3412–3417.
   PubMed Web of Science ®Google Scholar